PATENT CLAIM ANALYSIS

Application Number: 15868201
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["506", "009000"]

Abstract:
The present invention relates to the identification of chemokine biomarkers predictive of future acute coronary syndromes including unstable angina pectoris (UAP). The present invention also identifies particular chemokines as potential therapeutic targets for intervention in cardiovascular diseases.

Claim (Index 10):
The method according to  claim 1 , wherein the subject is identified as having an increased risk of a future acute cardiovascular syndrome or event if the sample from the subject was determined to have greater than 41 pg/ml CCL3, greater than 40.3 ng/ml CCL5, and/or greater than 39.3 ng/ml CCL18.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.13889
- Patent Class: 506.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12677437', '14388164', '15128560', '15171713', '13575354']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6478033696636593
- 35 USC 102 Novelty (BERT): 0.6325197248645698
- Combined Prediction Score: 0.6462750051837504
- Mean Citation Score: 379.722638
- Max Citation Score: 647.8530000000002
- Similarity Product: 523.1639290072919

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test